Agilon, Baby Boy .
HRN: 24-76-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/08/2024
04/15/2024
IV
20mg
Q24hrs
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes